Publications by authors named "Jean-Louis Formento"

Claim this Profile
M
Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan.
Marie-Christine Etienne-Grimaldi, Jaafar Bennouna, Jean-Louis Formento, Jean-Yves Douillard, Mireille Francoual

Br J Clin Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted picture.
Juliette Thariat, Marie-Christine Etienne-Grimaldi, Dominique Grall, René-Jean Bensadoun, Anne Cayre, Jean-Louis Formento

Clin Cancer Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer.
Laetitia Dahan, Emmanuelle Norguet, Marie-Christine Etienne-Grimaldi, Jean-Louis Formento, Mohamed Gasmi

BMC Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.
Marie-Christine Etienne-Grimaldi, Patricia Formento, Armelle Degeorges, Jean-Yves Pierga, Rémi Delva, Jean-Louis Formento

Br J Clin Pharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.
Marie-Christine Etienne-Grimaldi, Gérard Milano, Frédérique Maindrault-Goebel, Benoist Chibaudel, Jean-Louis Formento

Br J Clin Pharmacol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines.
Laetitia Dahan, Amine Sadok, Jean-Louis Formento, Jean François Seitz, Hervé Kovacic

Br J Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer.
Jean-Louis Formento, Marie-Christine Etienne-Grimaldi, Mireille Francoual, Gilles Pagès, Cercina Onesto, Patricia Formento

Pharmacogenomics· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
Marie-Christine Etienne-Grimaldi, Jean-Louis Formento, Mireille Francoual, Eric François, Patricia Formento

Clin Cancer Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidate mechanisms for capecitabine-related hand-foot syndrome.
Gérard Milano, Marie-Christine Etienne-Grimaldi, Mireille Mari, Sandra Lassalle, Jean-Louis Formento

Br J Clin Pharmacol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylenetetrahydrofolate reductase (MTHFR) variants and fluorouracil-based treatments in colorectal cancer.
Marie-Christine Etienne-Grimaldi, Mireille Francoual, Jean-Louis Formento, Gérard Milano

Pharmacogenomics· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU-related toxicity.
Nicolas Magné, Marie-Christine Etienne-Grimaldi, Laurent Cals, Nicole Renée, Jean-Louis Formento

Br J Clin Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of capecitabine in advanced breast cancer patients.
Rémy Largillier, Marie-Christine Etienne-Grimaldi, Jean-Louis Formento, Joseph Ciccolini, Jean-François Nebbia

Clin Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical patterns of circadian clock gene expression in human peripheral blood mononuclear cells.
Michèle Teboul, Marie-Audrey Barrat-Petit, Xiao Mei Li, Bruno Claustrat, Jean-Louis Formento

J Mol Med (Berl)· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxotere-5'-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells.
Jean-Louis Fischel, Jean-Marc Ferrero, Patricia Formento, Joseph Ciccolini, Nicole Renée, Jean-Louis Formento

Anticancer Drugs· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer.
Xavier Pivot, Nicolas Magné, Emmanuel Guardiola, Gilles Poissonnet, Olivier Dassonville, Jean-Louis Formento

Oral Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.
Marie-Christine Etienne, Jean-Louis Formento, Maurice Chazal, Mireille Francoual, Nicolas Magné, Patricia Formento

Pharmacogenetics· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring NF-kappa B transactivation potential via real-time PCR quantification of I kappa B-alpha gene expression.
Virginie Bottero, Véronique Imbert, Catherine Frelin, Jean-Louis Formento, Jean-François Peyron

Mol Diagn· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.
Nicolas Magné, Jean-Louis Fischel, Alain Dubreuil, Patricia Formento, Joseph Ciccolini, Jean-Louis Formento

Clin Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.
Marie-Christine Etienne, Maurice Chazal, Pierre Laurent-Puig, Nicolas Magné, Christophe Rosty, Jean-Louis Formento, Patricia Formento

J Clin Oncol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis